Targeted snakebite therapies and antivenom research for safer treatments
Official title: Viper Resource Grant at Texas A&M University-Kingsville
Funded at Texas A&m University-Kingsville · NIH-11330628 · Data updated 2026-11-12
Researchers are exploring new ways to improve treatments for snakebites by studying natural resistance in animals and creating better antivenoms and toxin tests.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m University-Kingsville NIH-funded |
| Lab location | 1 site (Kingsville, United States) |
| Project start | April 15, 2003 |
| Project end | April 30, 2029 |
| Funding year | 2026 |
| Award (this year) | $55,114 |
| NIH project number | 5P40OD010960-23 |
| Project ID | NIH-11330628 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are people at risk of snakebite exposure or clinicians and researchers seeking improved antivenom therapies and diagnostic tools.
✕Less likely to help
Individuals not involved in snakebite exposure or treatment development may not directly benefit.
What this research studies
This project focuses on understanding how certain animals resist snake venom and using those insights to develop next-generation antivenoms. It includes creating cell-based assays and testing toxin-inhibiting molecules to improve safety and effectiveness. Researchers will also enhance resources and services for researchers and clinicians working on snakebite treatment.
Why it matters
Potential benefit: It could lead to safer, more effective antivenoms and faster, more accurate toxin tests for snakebite patients.
How similar studies have gone: Previous work in venom biology and antivenom development has shown promise in translating basic findings into better therapies.
Where this research is happening
-
Texas A&m University-Kingsville
Kingsville, United States Active
Researchers
- Principal investigator: Sanchez, Elda E. — Texas A&m University-Kingsville
- Study coordinator: Sanchez, Elda E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.